Ciara Curtin

The panels assess genes with strong disease links and clinical management guidelines, but the firm offers limited-evidence genes as an add-on option.

After years of persistence, genetic counselors at UT Southwestern got BCBS of Texas to fix a system error that was leading to payment denials for services.

Drugmakers and insurers are exploring different payment schemes for expensive, potentially curative treatments, particularly ones tied to patient response.

During a panel discussion at the National Society of Genetic Counselors meeting, genetic counselors discussed the risks and benefits of gene therapies.

The algorithm, developed by Stanford University researchers, has been commercialized and rolled out at hundreds of hospitals or health systems.

At the meeting, companies and academic centers presented early and long-term follow-up data on investigational cell therapies in several tumor types. 

A model of these three measures improved heart disease risk predictions over any one measure, researchers reported at the American College of Cardiology meeting.

By sharing data, the working group found that patients with certain DMD gene deletions were experiencing muscle inflammation, including of the heart, from their gene therapies.

A randomized controlled trial compared cytochrome P450 genotype-based dosing of tricyclic antidepressants to usual care among patients with depression.

The panel focused on access and equity issues of precision medicine, especially ones that arise as sequencing is folded into newborn screening programs.